Keyword: adjuvant

2 records found.

Potential of Enzymatically Synthesi-2024-Hoshi.pdf
Potential of Enzymatically Synthesized Hemozoin Analog as Th1 Cell Adjuvant
Journal article
Creator
Kazuaki Hoshi (author) (Search by this author)
;
Anh Thi Tram Tu (author) (Search by this author)
;
Miwako Shobo (author) (Search by this author)
;
Karin Kettisen (author) (Search by this author)
;
Lei Ye (author) (Search by this author)
ORCID ;
Leif Bülow (author) (Search by this author)
ORCID ;
Yoji Hakamata (author) (Search by this author)
ORCID ;
Tetsuya Furuya (author) (Search by this author)
ORCID ;
Ryutaro Asano (author) (Search by this author)
ORCID ;
Wakako Tsugawa (author) (Search by this author)
ORCID ;
Kazunori Ikebukuro (author) (Search by this author)
ORCID ;
Koji Sode (author) (Search by this author)
ORCID ; ORCID SAMURAI
Keyword
hemozoin analog, heme detoxification protein, adjuvant, vaccine, Th-1 immunity
Date published
2024-09-03
Updated at
2024-10-04 12:30:16 +0900

2024 Vaccines -Xia Li.pdf
Synergistic effects of metal-organic nanoplatform and guanine quadruplex-based CpG oligodeoxynuceotides in therapeutic cancer vaccines with different tumor antigens
Journal article
Creator
Xia Li (author) (Search by this author)
Research Center for Macromolecules and Biomaterials/Biomaterials Field/Smart Polymers Group, National Institute for Materials Science
ORCID SAMURAI ;
Mitsuhiro Ebara (author) (Search by this author)
Research Center for Macromolecules and Biomaterials/Biomaterials Field/Smart Polymers Group, National Institute for Materials Science
ORCID SAMURAI ;
Naoto Shirahata (author) (Search by this author)
Research Center for Materials Nanoarchitectonics (MANA)/Nanomaterials Field/Nanoparticle Group, National Institute for Materials Science
ORCID SAMURAI ;
Tomohiko Yamazaki (author) (Search by this author)
Research Center for Macromolecules and Biomaterials/Biomaterials Field/Medical Soft Matter Group, National Institute for Materials Science
ORCID SAMURAI ;
Nobutaka Hanagata (author) (Search by this author)
ORCID SAMURAI
Keyword
TLR9 agonist, CpG oligodeoxynucleotides, nanoplatform, cancer vaccines, adjuvant
Date published
2024-06-11
Updated at
2024-06-28 08:30:16 +0900